By the Regenerative Evidence Guide Team What "Eligibility Criteria" Means Every public clinical trial record lists eligibility criteria — the requirements researchers use to decide who can join a …
Research Injury Costs: Questions Before Joining a Study
By the Regenerative Evidence Guide Team A research-related injury is any harm caused by taking part in a study — and before you join one, federal rules require the consent form to tell you whether …
Continue Reading about Research Injury Costs: Questions Before Joining a Study →
Expanded Access vs. Clinical Trials: FDA Pathways Explained
By the Regenerative Evidence Guide Team Expanded access and clinical trial participation are two different FDA pathways to an unapproved product, and confusing them is an easy, costly mistake. A …
Continue Reading about Expanded Access vs. Clinical Trials: FDA Pathways Explained →
Clinical Trial Status Labels Explained: Recruiting, Active, and Completed
By the Regenerative Evidence Guide Team Clinical trial status labels describe where a study sits in its enrollment timeline, not whether the treatment works. "Recruiting" means the study is currently …
Continue Reading about Clinical Trial Status Labels Explained: Recruiting, Active, and Completed →
What “FDA Registered” Can Mean for a Regenerative-Medicine Claim
By the Regenerative Evidence Guide Team What Does "FDA Registered" Mean? "FDA registered" means a facility has told the FDA where it operates and what it makes there. It does not mean the FDA …
Continue Reading about What “FDA Registered” Can Mean for a Regenerative-Medicine Claim →
A Study Protocol and a Study Result: Why the Difference Matters
By the Regenerative Evidence Guide Team What Is a Study Protocol vs. a Study Result? A study protocol is the written plan for a clinical trial — what will be tested, on whom, and how the outcome will …
Continue Reading about A Study Protocol and a Study Result: Why the Difference Matters →